Treace Medical Concepts TMCI
NASDAQ TMCI
$4.35 -0.21 (-4.61%)
At close: Aug 20, 2026 · 2:33 PM UTC

Treace Medical Concepts (TMCI) Total Debt Growth (1y) (2021 - 2026)

Treace Medical Concepts (TMCI) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn 142.67%
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn -9.88%
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn -1.95%
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 1,188.16%
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 0.12%
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn -17.79%
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -9.03%
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn -0.50%
10 Treace Medical Concepts 282.97 Mn 237.35 Mn 35.61 Mn 8.51%

Historic Data

Download Data
DateValue
Jun 30, 2026 8.51%
Mar 31, 2026 7.81%
Dec 31, 2025 7.55%
Sep 30, 2025 3.94%
Jun 30, 2025 2.65%
Mar 31, 2025 0.64%
Dec 31, 2024 0.56%
Sep 30, 2024 0.56%
Jun 30, 2024 0.56%
Mar 31, 2024 0.56%
Dec 31, 2023 0.56%
Sep 30, 2023 0.57%
Jun 30, 2023 0.57%
Mar 31, 2023 79.48%
Dec 31, 2022 79.50%
Sep 30, 2022 79.52%
Jun 30, 2022 79.53%
Mar 31, 2022 0.61%
Dec 31, 2021 -5.20%